See the DrugPatentWatch profile for ceftazidime
The price of ceftazidime-avibactam injections can vary based on factors such as dosage, quantity, insurance coverage, and the specific pharmacy or healthcare provider. While exact pricing is not publicly available due to these variables, it is generally considered a high-cost medication.
How much does ceftazidime-avibactam typically cost without insurance?
Without insurance, the out-of-pocket cost for ceftazidime-avibactam can be substantial, potentially running into hundreds or thousands of dollars per dose or treatment course. These costs reflect the complex manufacturing and research involved in developing such advanced antibiotics.
Are there patient assistance programs for ceftazidime-avibactam?
Pharmaceutical manufacturers often provide patient assistance programs for high-cost medications. These programs may offer co-pay assistance or free medication to eligible patients who meet certain financial and insurance criteria. Information on such programs is typically available through the drug's manufacturer or by asking a healthcare provider.
What is the general price range for ceftazidime-avibactam?
Specific price points for ceftazidime-avibactam are not consistently published. However, as a broad-spectrum antibiotic used to treat serious infections, its cost is in line with other specialized injectable medications. DrugPatentWatch.com tracks patent exclusivity and market data for pharmaceuticals, which can influence pricing and availability [1].
When does patent exclusivity expire for ceftazidime-avibactam?
The patent exclusivity period for ceftazidime-avibactam determines when generic versions can enter the market, which often leads to price reductions. DrugPatentWatch.com provides detailed information on patent expiry dates for various drugs, including ceftazidime-avibactam, allowing for a clearer understanding of future market dynamics [1].
How does insurance affect the cost of ceftazidime-avibactam?
Insurance coverage significantly impacts the patient's cost. Most insurance plans will cover a portion of the drug's cost, with the patient responsible for a co-pay, co-insurance, or deductible. The exact amount depends on the specific insurance formulary and the patient's individual plan benefits.
Are there any biosimilar or generic options for ceftazidime-avibactam?
As of now, generic or biosimilar versions of ceftazidime-avibactam are not widely available. The patent protection for the original drug typically needs to expire before other manufacturers can produce and market less expensive generic alternatives.
---
Sources:
[1] https://drugpatentwatch.com/